MEDIFAST INC

 MEDのチャート


 MEDの企業情報

symbol MED
会社名 Medifast Inc (MEDIFAST INC)
分野(sector)   
産業(industry)   
業種 食品加工   一般消費財(Consumer Products)
概要 メディファスト(Medifast Inc)は体重管理と疾病管理製品及び他の健康・栄養製品の生産、流通と販売に従事する会社である。同社の商品ラインは減量、体重管理、健康的生活食の代替品、軽食、水分補給製品、ビタミンが含まれる。事業にはOptavia、Medifast Direct、Franchise Medifast Weight Control Centers(MWCC)、Medifast Wholesaleが含まれる。OptaviaはOptaviaプラットフォームを利用している顧客にコーチングとサポートを提供するOptavia Coachesで構成される同社のパーソナルコーチング部門である。Medifast Directは顧客が自社のウェブサイトまたは社内のコールセンターを通じて直接Medifast製品を注文することができる消費者向けビジネスユニットである。MWCC事業はフランチャイズおよびリセラーの店舗を通じて製品を販売し、構造化プログラムと減量・重量管理の成功を達成するための専門家チームを提供する。  メディファストは減量、体重管理、栄養補助食品を製造、販売。同社のウェブサイト、コ―ルセンタ―、医師を通じて調理済み食品、スナック、ビタミンを販売。また、減量プログラムの個人指導サ―ビス「テイク・シェイプ・フォ―・ライフ」を提供するほか、米国8州に75カ所の体重管理センタ―を展開。  Medifast is the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, which offers scientifically developed products, clinically proven plans and the support of Coaches and a Community to help Clients achieve Lifelong Transformation, One Healthy Habit at a Time®. Based on nearly 40 years of experience, Medifast has redefined direct selling by combining the best aspects of the model. Its community of thousands of independent OPTAVIA Coaches teach Clients how to develop holistic healthy habits through the proprietary Habits of Health® Transformational System. Medifast is ranked second on FORTUNE's 100 Fastest-Growing Companies list in 2020. The company was also named to Forbes' 100 Most Trustworthy Companies in America list in 2017.
本社所在地 100 International Drive Baltimore MD 21202 USA
代表者氏名 Daniel R. Chard
代表者役職名 Chief Executive Officer Director
電話番号 +1 732-764-0619
設立年月日 32629
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 420人
url www.medifastnow.com
nasdaq_url
adr_tso
EBITDA (百万ドル) 73.49800
終値(lastsale)
時価総額(marketcap)
時価総額 (百万ドル) 1583.28000
売上高 (百万ドル) 501.00300
企業価値(EV) (百万ドル) 1482.24600
当期純利益 (百万ドル) 55.78900
決算概要 BRIEF: For the fiscal year ended 31 December 2018 Medifast Inc revenues increased 66% to $501M. Net income before extraordinary items increased 98% to $55.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Interest income net increase from $558K to $1.3M (income) Other income (expense) increase of 32% to $179K (income).

 MEDのテクニカル分析


 MEDのニュース

   Here Are 4 Beaten-Down Small-Caps With Solid Yields—and Solid Fundamentals  2022/03/02 19:14:00 Barron''s
Medifast and La-Z-Boy are among a group of struggling small-cap stocks that appear to have the wherewithal to keep paying dividends.
   Medifast GAAP EPS of $2.91 beats by $0.26, revenue of $377.8M beats by $2.01M  2022/02/23 21:11:42 Seeking Alpha
Medifast press release (MED): GAAP EPS of $2.91 beats by $0.26.Revenue of $377.8M (+42.6% Y/Y) beats by $2.01M.Outlook: The company expects full-year 2022 revenue to be in the range…
   Medifast, Inc. Announces Fourth Quarter and Full Year 2021 Financial Results  2022/02/23 21:05:00 PR Newswire
BALTIMORE, Feb. 23, 2022 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today reported results for the fourth quarter and full year ended December 31, 2021. Fourth Quarter 2021 Highlights Compared…
   Medifast Q4 2021 Earnings Preview  2022/02/22 22:35:17 Seeking Alpha
Medifast (NYSE:MED) is scheduled to announce Q4 earnings results on Wednesday, February 23rd, after market close.The consensus EPS Estimate is $2.65 and the consensus Revenue Estimate
   MEDIFAST INC – Consensus Indicates Potential 82.4% Upside  2022/02/17 13:36:57 DirectorsTalk
MEDIFAST INC with ticker code (MED) now have 3 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 350 and 345 with a mean TP of 348. With the stocks previous close at 190.8 this would imply there is a potential upside of 82.4%. The day 50 moving average is 201.46 and the 200 moving average now moves to 235.64. The company has a market cap of $2,222m. Find out more information at: https://medifastinc.com [stock_market_widget type="chart" symbol="MED" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] The potential market cap would be $4,052m based on the market concensus. Medifast, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. It offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands.
   Medifast, Inc. (NYSE:MED) Stake Boosted by WINTON GROUP Ltd  2021/12/20 10:26:45 Dakota Financial News
WINTON GROUP Ltd grew its stake in shares of Medifast, Inc. (NYSE:MED) by 1.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,683 shares of the specialty retailers stock after purchasing an additional 74 shares during the quarter. WINTON GROUP Ltds holdings []
   Medifast (MED) Investor Presentation - Slideshow  2021/12/18 06:06:39 Seeking Alpha
   Insight Wealth Strategies LLC Has $281,000 Stake in Medifast, Inc. (NYSE:MED)  2021/12/17 14:30:44 Dakota Financial News
Insight Wealth Strategies LLC increased its holdings in Medifast, Inc. (NYSE:MED) by 4.7% in the third quarter, Holdings Channel reports. The institutional investor owned 1,461 shares of the specialty retailer’s stock after buying an additional 66 shares during the period. Insight Wealth Strategies LLC’s holdings in Medifast were worth $281,000 at the end of the […]
   Medifast, Inc. (NYSE:MED) Shares Sold by Robeco Institutional Asset Management B.V.  2021/12/11 11:18:42 Transcript Daily
Robeco Institutional Asset Management B.V. decreased its holdings in shares of Medifast, Inc. (NYSE:MED) by 44.7% during the 3rd quarter, Holdings Channel.com reports. The firm owned 8,448 shares of the specialty retailers stock after selling 6,833 shares during the period. Robeco Institutional Asset Management B.V.s holdings in Medifast were worth $1,627,000 at the end of []
   Medifast, Inc. (NYSE:MED) Declares Quarterly Dividend of $1.42  2021/12/09 22:14:44 Dakota Financial News
Medifast, Inc. (NYSE:MED) announced a quarterly dividend on Thursday, December 9th, Wall Street Journal reports. Shareholders of record on Tuesday, December 21st will be paid a dividend of 1.42 per share by the specialty retailer on Tuesday, February 8th. This represents a $5.68 annualized dividend and a yield of 2.84%. The ex-dividend date of this […]
   Medifast Q2 2021 Earnings Preview  2021/08/03 16:46:24 Seeking Alpha
   MEDIFAST INC Consensus Indicates Potential 30.1% Upside  2021/07/29 10:07:38 DirectorsTalk
MEDIFAST INC with ticker code (MED) have now 3 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 395 and 325 with a mean TP of 356.67. With the stocks previous close at 274.22 this indicates there is a potential upside of 30.1%. The day 50 moving average is 279.7 and the 200 moving average now moves to 259.72. The market cap for the company is $3,294m. Find out more information at: /> [stock_market_widget type="chart" symbol="MED" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Medifast, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. It offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands.
   Medifast: A Rare Combination Of Growth, Profitability, And A Good Price  2021/07/25 16:41:10 Seeking Alpha
   Weight Control Market is Mounting at a Vigorous CAGR in the Forecast Period 2021-2027 | Abbott Nutrition, Bio-Synergy, Ajinomoto, Nestle, Atkins Nutritionals, Kellogg Company, Medifast, Herbalife International  2021/07/23 15:16:42 OpenPR
Worldwide Market Reports published a new version of the Weight Control Market Research Report in the year 2021 which provides forecast data until 2027. This report offers detailed insights on the global Weight Control market focusing insights on its different
   Should I Buy Medifast, Inc. (MED)?  2021/07/20 03:43:22 Insider Monkey

 twitter  (公式ツイッターやCEOツイッターなど)